Register to chat with like-minded investors on our interactive forums.
Period:
Draw Mode:
| Volume | 343,590 |
|
|||||
| News | - | ||||||
| Day High | 14.96 | Low High |
|||||
| Day Low | 13.60 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Cidara Therapeutics Inc | CDTX | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 1.48 | 12.06% | 13.7718 | 10:01:13 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 14.50 | 13.60 | 14.96 | 12.29 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 5,930 | 343,590 | $ 14.20 | $ 4,878,685 | - | 10.004 - 29.60 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 10:01:35 | 4 | $ 13.80 | USD |
Cidara Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 1.28B | 90.43M | - | 64.29M | -29.8M | -0.33 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Cidara Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CDTX Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 14.40 | 14.998 | 10.004 | 10.72 | 1,322,069 | -0.6282 | -4.36% |
| 1 Month | 17.20 | 24.40 | 10.004 | 17.13 | 1,242,980 | -3.43 | -19.93% |
| 3 Months | 13.20 | 24.40 | 10.004 | 15.85 | 743,646 | 0.5718 | 4.33% |
| 6 Months | 16.668 | 24.40 | 10.004 | 15.60 | 677,538 | -2.90 | -17.38% |
| 1 Year | 21.60 | 29.60 | 10.004 | 18.80 | 682,445 | -7.83 | -36.24% |
| 3 Years | 44.20 | 47.80 | 8.00 | 24.61 | 806,399 | -30.43 | -68.84% |
| 5 Years | 45.80 | 89.00 | 8.00 | 31.55 | 637,068 | -32.03 | -69.93% |
Cidara Therapeutics Description
| Cidara Therapeutics Inc is a biotechnology company. It is focused on the discovery, development, and commercialization of novel anti-infectives for the treatment and prevention of diseases. The company's Rezafungin is a novel molecule in the echinocandin class of antifungals. It is developing rezafungin for the first-line treatment and prevention of serious, invasive fungal infections which are associated with high mortality rates. |
